Most people today want to be as proactive as possible when it comes to preventative health care. Many diagnostic tests are available today that can help to predict potential threats to patient wellness before they manifest. Cardiovascular genetic testing is recommended in order to serve the needs of patients, especially those from families whose members seem especially prone to heart disease, in the most efficient, proactive manner possible.

What are the Benefits of Cardiovascular Genetic Testing?

Testing can detect tendencies that point out vulnerabilities to the varied types of heart conditions that tend to run in families. Genetic testing can give us a “heads up”; and prompt us to take action in time to prevent a crisis. The following summaries are ways in which cardiovascular genetic testing can be of benefit.

Supporting a Diagnosis

Genetic testing offers additional evidence to support a cardiologist’s diagnosis of a particular condition. It can help to differentiate from other causes of symptoms in cases where there is no clear diagnosis based on symptoms and test results. Genetic tests can provide additional diagnostic input  for conditions that demand more complex considerations in order to arrive at an official diagnosis.

Testing of multiple family members can identify those who may be vulnerable to certain cardiovascular conditions, so they may be treated or advised to take preventive measures before symptoms manifest, and to be alert to the start of a problem, so they can pre-emptively notify their cardiologist.

Improving Prognosis

The ability to inform patients, and possibly vulnerable family members of their genetic tendencies toward developing particular heart conditions is not only key in preventing life threatening symptoms from issues such as arrhythmias, aortic dissections, heart failure. The earlier the risk for such problems are discovered, the more promising the outcome should treatment become necessary.

Additionally, response to pharmacotherapies can better be predicted when genetic conditions are known. This allows the Physician to prescribe, treat and prescribe more definitively.

Management of Patient Wellness and Treatment is More Efficiently Organized

The informed treatment facilitated through cardiovascular genetic testing enables providers to avoid prescribing medications that may contribute to certain heart disease and to advise patients to avoid lifestyle choices that may speed the development of heart conditions to which they may be vulnerable.

The decision to implant an automatic defibrillator or pacemaker can be made easier when indications are supported by genetic evidence of the necessity.

Prompt initiation of enzyme replacement therapy, early surgical intervention, heart transplantation, and other procedures that save lives when implemented in time, will be supported when genetic factors verify the need.

Appropriate screening intervals can be determined for each family member who has been tested, based upon indications provided by cardiovascular genetic tests. Screening will show when it is time for intervention procedures to be taken to prevent the onset, or treat, conditions of serious heart disease.

The Framingham Heart Study Supports Genetic Risk Research

Famous for naming smoking and cholesterol as risk factors in the development of heart disease, the Framingham Heart Study may be on it’s way to becoming the gold standard in cardiovascular genetic epidemiology, some say.

This landmark study has also meticulously collected the amount of genetic information necessary, from an immense number of individuals to conduct groundbreaking research on how genetics affects our cardiovascular health. The referenced article was posted in 2007. Genetic Cardiovascular research has come a long way since then. It is now mainstream in preventing unnecessary symptoms and deaths due to cardiovascular conditions. 

Tesis biosciences offers cardiovascular heart disease screening for patients exhibiting a variety of symptoms. Testing can assist with the diagnosis of and reveal risk factors for conditions like sudden infant death syndrome and unexplained fainting, that may run in families, in addition to cardiovascular disorders.